These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 20674880

  • 21. Measles and rubella immunization. Statement of the Committe on Infectious Diseases, American Academy of Pediatrics.
    Postgrad Med; 1977 Jan; 61(1):269-72. PubMed ID: 834685
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Measles--Puerto Rico, 1993, and the measles elimination program.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Mar 11; 43(9):171-3. PubMed ID: 8164642
    [Abstract] [Full Text] [Related]

  • 24. Surveillance of rubella since the MR vaccination campaign.
    Commun Dis Rep CDR Wkly; 1995 Apr 28; 5(17):81. PubMed ID: 7749459
    [No Abstract] [Full Text] [Related]

  • 25. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC, Burgess MA, O'Brien ED.
    Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551
    [No Abstract] [Full Text] [Related]

  • 26. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts.
    Doshi S, Khetsuriani N, Zakhashvili K, Baidoshvili L, Imnadze P, Uzicanin A.
    Int J Epidemiol; 2009 Feb 06; 38(1):182-91. PubMed ID: 19074954
    [Abstract] [Full Text] [Related]

  • 27. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C.
    Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126
    [Abstract] [Full Text] [Related]

  • 28. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S, Tabu C, N'ganga J, Awes AA, Sergon K, Cosmas L, Styczynski A, Thuo S, Lebo E, Kaiser R, Perry R, Ademba P, Kretsinger K, Onuekwusi I, Gary H, Scobie HM.
    PLoS One; 2018 Feb 07; 13(7):e0199786. PubMed ID: 29965975
    [Abstract] [Full Text] [Related]

  • 29. Measles-Rubella Campaign: Could Things Have Been Done Differently?
    Sanklecha M.
    Indian Pediatr; 2019 Apr 15; 56(4):335. PubMed ID: 31064912
    [No Abstract] [Full Text] [Related]

  • 30. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003 Apr 15; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 31. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 32. Measles, mumps and rubella: control by vaccination.
    van Druten JA, de Boo T, Plantinga AD.
    Dev Biol Stand; 1986 Jun 10; 65():53-63. PubMed ID: 3556777
    [Abstract] [Full Text] [Related]

  • 33. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI, Nakamura MA, Godoy MV, Kuri P, Lucas CA, Conyer RT.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [Abstract] [Full Text] [Related]

  • 34. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic.
    Ehrenkranz NJ, Ventura AK, Medler EM, Jackson JE, Kenny MT.
    Bull World Health Organ; 1975 May 01; 52(1):81-5. PubMed ID: 764997
    [Abstract] [Full Text] [Related]

  • 35. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues.
    Pless RP, Bentsi-Enchill AD, Duclos P.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S291-8. PubMed ID: 12721928
    [Abstract] [Full Text] [Related]

  • 36. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P.
    Ann Ig; 1998 May 15; 10(1):19-24. PubMed ID: 9616974
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Measles and rubella elimination in the Eastern Mediterranean Region: successes and challenges.
    Teleb N, Atta H, Hajjeh R.
    East Mediterr Health J; 2019 Nov 04; 25(10):667-668. PubMed ID: 31774131
    [Abstract] [Full Text] [Related]

  • 39. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A, Torner N, Martínez A, Costa J, Plans P, Ciruela P, Salleras L.
    Vaccine; 2006 Feb 27; 24(9):1433-7. PubMed ID: 16226357
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.